Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HPV-Related Squamous Cell Carcinoma × cemiplimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 5 Skin Neoplasms 5 Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Merkel Cell 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Mycosis Fungoides 3 Melanoma 3 Carcinoma, Squamous Cell 3 Breast Neoplasms 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Oropharyngeal Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Vulvar Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1

Interventions

cemiplimab 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04988074 2026-03-03

MINIMA

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

HPV-Related Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡